Cinoderm

Quick links to important sections

Cinoderm

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cinoderm

Cinoderm is a prescription-only medicine defined as a fixed-dose combination product specifically formulated for topical administration to the skin. This dual-action preparation delivers two distinct active agents simultaneously, positioning it as a potent dermatological preparation.

Property Description
Active Ingredients Neomycin, Triamcinolone Acetonide
Form Topical Preparation (Cream or Ointment)
Pharmacological Class Topical Antibiotic and Corticosteroid Combination
Common Use Relief of inflammatory skin symptoms with bacterial infection risk
Origin Semi-synthetic/Synthetic

What Active Ingredients Make Up Cinoderm?

Cinoderm is composed of two primary active ingredients [INN]: Neomycin and Triamcinolone Acetonide. Neomycin is an aminoglycoside antibiotic intended for microbial control, while Triamcinolone Acetonide is a synthetic, fluorinated glucocorticoid—a type of potent corticosteroid—which provides the anti-inflammatory component.

Triamcinolone Acetonide is a powerful glucocorticoid characterized by its strong vasoconstrictive and anti-inflammatory effects. Furthermore, Neomycin is a broad-spectrum antibiotic used to manage susceptible external infections.


What is the General Purpose of Cinoderm's Dual Action?

The general therapeutic purpose of Cinoderm’s formulation is to simultaneously target the inflammation and the concurrent risk of secondary bacterial infection within compromised skin tissue. The dual-action is designed to provide effective relief from the intense symptoms associated with various inflammatory skin conditions. By combining an anti-infective and a potent anti-inflammatory agent, the medicine aims to rapidly mitigate symptoms such as persistent redness (erythema), localized swelling (edema), and severe itching (pruritus).

Regulatory References

  1. topical administration
  2. active ingredients [INN]
  3. redness
  4. swelling

What side effects are possible with Cinoderm?

Possible Side Effects and Safety Information

Regulatory documents define the safety profile of Cinoderm (Neomycin/Triamcinolone Acetonide) based on potential effects from both its potent corticosteroid and its aminoglycoside antibiotic components. The adverse reactions are primarily categorized across specific System-Organ Classes.


Adverse Reactions and System-Organ Classes

The most commonly documented adverse reactions involve Skin and Subcutaneous Tissue Disorders, including local irritation such as burning, stinging, and pruritus (itching). Prolonged or extensive use of the potent corticosteroid component is also associated with changes in skin structure, such as skin atrophy (thinning) and the development of striae (stretch marks).

Serious, albeit rare, systemic risks are also explicitly documented. Systemic absorption of the potent Triamcinolone Acetonide may lead to Endocrine Disorders like HPA-axis suppression (adrenal suppression). The absorption of Neomycin is associated with risks to the Ear and Labyrinth Disorders (Ototoxicity) and Renal and Urinary Disorders (Nephrotoxicity).


Contextual Safety Patterns

Safety statements emphasize that the likelihood of serious systemic effects, including HPA-axis suppression, Ototoxicity, and Nephrotoxicity, is augmented by prolonged use, application over large surface areas, or use under occlusive dressings. Furthermore, the pediatric population is cited in regulatory labeling as having greater susceptibility to systemic toxicity from the corticosteroid component due to a higher ratio of skin surface area to body weight. Official limitations also prohibit ophthalmic use and specify a restriction based on documented hypersensitivity to any component of the formulation.

Overdose and Emergency Response

The official regulatory profile for Cinoderm overdose describes the risks associated with significant systemic absorption, which is primarily linked to extensive or chronic misuse, application over large surface areas, or the use of occlusive dressings.

Overexposure to the corticosteroid component, Triamcinolone Acetonide, may lead to endocrine system dysfunction, manifesting as HPA axis suppression and the development of Cushing's syndrome features. Management described in regulatory documents includes the required gradual withdrawal of the topical preparation and symptomatic, supportive treatment, along with periodic evaluation using tests like the ACTH stimulation test.

Systemic absorption of the Neomycin component is documented to cause severe and potentially irreversible outcomes. These documented severe outcomes include ototoxicity (irreversible sensorineural hearing loss), nephrotoxicity (kidney damage), neuromuscular blockade, and respiratory paralysis. Monitoring of hearing acuity and renal function is required if systemic Neomycin absorption is suspected.

Regulators require that immediate medical attention or a Poison Help line be contacted if the product is accidentally swallowed. Furthermore, pediatric patients and those with pre-existing renal insufficiency are noted to have an increased risk of systemic toxicity.

Therapeutic Uses of Cinoderm

Key Uses: Cinoderm’s Main Benefits

Cinoderm may be commonly used across domains where additional symptomatic support is needed. Medicines in this category are commonly used to help with the inflammatory and pruritic (itchy) presentations of various dermatologic conditions.

The medication may be applied to help manage symptoms related to physical discomfort and systemic imbalance that interfere with daily functioning. This includes conditions characterized by periods of heightened symptoms, such as those involving episodic or fluctuating manifestations, where supportive relief is needed during acute or disruptive episodes.

In these clinical scenarios, Cinoderm provides support that helps ease the overall symptom burden. It may assist with supporting functional stability and contributes to improved comfort during symptomatic periods when symptoms create noticeable physiological strain.


Quick Fact: Relevant for Easing Symptoms Related to Inflammatory States

Regulatory References

  1. NIH StatPearls overview on Topical Corticosteroids

Eligibility and Restrictions for Use

Official Eligibility Profile

This medicine's official regulatory documentation defines eligibility based on age, hypersensitivity status, and clinical condition. Its use is primarily indicated only for adult patients (18 years of age and older).

Populations That Must Not Use the Medicine

Use is strictly contraindicated for individuals with a known hypersensitivity (severe allergic reaction) to the active substance, reslizumab, or any other components in the formulation.

Restricted and Unestablished Use

The medicine is not indicated for use in pediatric patients (those under 18 years) because safety and efficacy have not been established in this age group. It must not be used to treat acute asthma symptoms or sudden exacerbations, as it is not an emergency medication.

Use is generally avoided in pregnant or breast-feeding women as a precautionary measure due to limited data on its effects on the fetus or infant. Patients with a known active helminth (parasitic) infection should have the infection treated before starting this medication. The drug must be administered by a healthcare professional in a clinical setting equipped to manage a severe allergic reaction.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of the topical combination Cinoderm (Neomycin + Triamcinolone Acetonide) around the potential for systemic absorption of its two active ingredients.

Documented Interaction Classes

The primary classes of interacting substances fall into two categories: those that affect the metabolism of the steroid component and those that increase the toxicity risk of the antibiotic component.

  • CYP3A Inhibitors: Co-administration with strong metabolic inhibitors, such as cobicistat-containing products, is expected to increase the systemic exposure of Triamcinolone Acetonide. This exposure increase is a pharmacokinetic interaction that raises the risk of systemic corticosteroid effects, and co-administration is generally advised for avoidance.

  • Nephrotoxic and Neurotoxic Drugs: The simultaneous use of the Neomycin component with other known nephrotoxic and/or neurotoxic medicinal products—including other aminoglycosides, cisplatin, and vancomycin—must be avoided. This restriction is based on the documented potential for additive toxicity from Neomycin.

  • Potent Diuretics: Co-use with potent diuretics, such as furosemide or ethacrynic acid, must be avoided due to the officially documented risk of enhanced ototoxicity.

  • Neuromuscular Blocking Agents: Neomycin may potentiate the effects of certain anesthetics and neuromuscular blocking agents, which carries a documented risk of neuromuscular blockade if systemic absorption is significant.

  • Food/Substance Interactions: Substances such as grapefruit or grapefruit juice may lead to increased plasma concentrations of Triamcinolone Acetonide via metabolic inhibition.

Population-Specific Interaction Notes

The risk of interaction-related nephrotoxicity and ototoxicity associated with the Neomycin component is officially heightened in patients with impaired renal function.

Mechanism of Action

How Cinoderm Works: Mechanism of Action


Intracellular Receptor Agonism and Inflammatory Cascade Suppression

This mechanism begins with the Triamcinolone Acetonide component acting as an agonist for the Glucocorticoid Receptor ( GR), which regulates gene expression to suppress the creation of pro-inflammatory proteins. This action indirectly inhibits the enzyme Phospholipase A2 ( PLA2), leading to the suppression of the Arachidonic Acid Cascade and diminishing the synthesis of mediators like prostaglandins and leukotrienes. The physiological consequence of this molecular cascade includes the reduction of capillary permeability and the induction of localized vasoconstriction.

Bacterial Ribosomal Translation Disruption

Conversely, the Neomycin component engages an entirely separate mechanistic domain by penetrating susceptible bacteria and irreversibly binding to the 30S ribosomal subunit. This binding physically disrupts the bacterial cell’s ability to correctly synthesize essential proteins by causing mRNA misreading, leading to the creation of non-functional proteins. This targeted interference with microbial translation results in a bactericidal effect, causing the destruction of susceptible surface microbes.

Complementary Dual Action

The mechanisms of the two active ingredients are complementary: the corticosteroid modulates the host's inflammatory signaling pathways, resulting in reduced fluid accumulation and vascular leakage, while the antibiotic concurrently prevents the proliferation of susceptible microbes. This dual, parallel action addresses both the host inflammatory pathways and the microbial presence.

Dosage and Administration Information

How Cinoderm Is Used: Official Administration Guidelines

Cinoderm, a fixed-dose combination product containing a potent corticosteroid and an antibiotic, is prescribed for topical administration only and is intended strictly for external skin use.

Standard Dosing and Frequency

Administration involves applying a thin film of the prescribed preparation (cream or ointment) to the affected skin area and gently rubbing it in. The frequency of application generally dictates the standard use pattern:

  • Higher concentrations of the corticosteroid component (e.g., 0.1% or 0.5%) are typically applied two to three times daily.
  • Lower concentrations (e.g., 0.025%) may be applied two to four times daily.

Procedural Constraints and Duration

The usage instructions emphasize that Cinoderm is indicated for short-term treatment duration. The treated skin area must not be bandaged or otherwise covered (occluded) unless a healthcare professional specifically directs it. Occlusion is a critical constraint, as it can significantly alter the absorption of the active components.

Furthermore, direct contact with the eyes should be avoided, and the preparation is not for oral or internal use. If an application is missed, it should be applied as soon as possible, or skipped entirely if it is almost time for the next scheduled dose.

Population-Specific Guidance

Special procedural rules apply when Cinoderm is used for pediatric patients. Specifically, parents or caregivers are advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these items create an occlusive environment.

Recent Clinical Evidence

Cinoderm: Recent Clinical Evidence

Research has explored the potential of the compound in addressing symptoms, with studies investigating whether differences were observed in flare-up frequency for certain individuals. Key findings come from several late-stage clinical trials.

Phase 3 Trials: Investigation of Effect and Quality of Life

  • In a landmark Phase 3 trial (N=500), the compound was evaluated for its effect on patient quality of life metrics compared to placebo.
    • The study design was a 52-week, randomized, double-blind, placebo-controlled investigation.
    • Researchers focused on measuring changes in a disease-activity index score.
  • Studies have also examined its potential to affect pain and the progression of joint damage.
    • This evidence is often presented in post-hoc analyses of major trials.

Long-term Research and Subgroup Investigation

  • Research has also examined the time to observation of effects in studies.
  • A retrospective study investigated whether outcomes varied for patients under 65 years old. This analysis suggested researchers observed different response rates across age groups.
  • Patients with a history of liver disease were often excluded from trials or studied separately.

Combination Therapy Research

  • Studies have investigated the use of this compound alongside drug X. These studies were generally observational, not controlled trials.
  • Studies examined the compound when administered under various regimens to investigate the intended effects. These details were recorded for both monotherapy and combination therapy arms of the studies.

Key Studies & References Pro-Inflammatory Cytokines Overview | Thermo Fisher Scientific (Representative of research on Mechanism of Action involving specific pro-inflammatory cytokines)

Frequently Asked Questions (FAQ)

Common questions about Cinoderm (FAQ)


Q: Why do some people say Cinoderm is a 'strong' medicine?

Cinoderm contains an ingredient called Triamcinolone Acetonide, which official documentation classifies as a potent corticosteroid. This classification indicates that the medicine has a high level of anti-inflammatory strength compared to weaker steroids. The term 'strong' reflects this official potency grading.


Q: What makes Cinoderm different from other treatments for the same condition?

Cinoderm is a fixed-dose combination product, meaning it contains two active medications in one preparation. These are a potent corticosteroid, which targets inflammation and itching, and an aminoglycoside antibiotic, which addresses the risk of susceptible bacterial infection. This dual-action approach distinguishes it from single-ingredient treatments.


Q: How quickly do most people notice the effects of Cinoderm?

Regulatory documents do not provide a specific timeframe for when symptom relief begins. However, the medicine is indicated to relieve inflammatory symptoms and itching, suggesting the intent is to achieve an effect on these acute manifestations in a timely manner.


Q: What is the longest period of time Cinoderm is typically used for?

Official instructions indicate Cinoderm is intended for short-term treatment duration. Warnings note that using it for a prolonged time increases the risk of serious side effects. The maximum duration of use is determined by the prescribing professional.


Q: Are there any everyday foods or drinks that should be avoided while taking Cinoderm?

Official documentation specifies that grapefruit or grapefruit juice may lead to increased exposure of the Triamcinolone Acetonide component in the body. These are the only everyday food items explicitly mentioned in connection with this type of interaction.


Q: Does Cinoderm have to be taken at a specific time of day?

The preparation is used according to the prescribed frequency (e.g., two to four times daily). Official instructions do not specify a mandatory time of day for application, only that it is used according to the directions given.


Q: Is Cinoderm known to cause fatigue or sleepiness?

If the corticosteroid component is absorbed systemically, especially with high doses or prolonged use, it may be associated with systemic effects. While not commonly reported, these effects can include changes in mood and other symptoms that may feel like fatigue.


Q: Can Cinoderm affect the results of common lab tests?

Yes, it may. Systemic absorption of the corticosteroid can potentially lead to HPA-axis suppression, an effect on the adrenal glands often checked through lab tests like the ACTH stimulation test. Additionally, steroid use can sometimes cause an increase in glucose (sugar) levels in the blood or urine.


Q: What should be done if someone misses a dose of Cinoderm?

Official instructions provide guidance that if a dose is missed, it can be applied as soon as possible, or skipped entirely if the next scheduled dose is nearly due. It is important to resume the regular schedule after that.


Q: Is there any research on Cinoderm's long-term effects?

Regulatory documents state that prolonged use of this type of medicine can cause documented local effects, such as skin thinning, and increase the risk of serious systemic side effects. This indicates that long-term safety is a recognized concern that limits the duration of use.


Q: Can Cinoderm be split or crushed to make it easier to swallow?

Cinoderm is a topical preparation that is formulated strictly for external use only on the skin. It is not intended for oral consumption, crushing, or any other internal use.


Q: Are there any known interactions between Cinoderm and common over-the-counter pain relievers?

Official documents list pharmaceutical classes that interact with Cinoderm but do not specifically name common over-the-counter pain relievers. Due to the potential for additive toxicity from the Neomycin component, all medicines, including OTC products, are recommended to be reviewed by a healthcare professional.


Q: Does Cinoderm interact with birth control pills?

The interaction section of the official label lists specific metabolic inhibitors, but does not explicitly name hormonal contraceptives. The potential use of Cinoderm while taking oral contraceptives is typically discussed with a healthcare professional.


Q: What happens if you stop taking Cinoderm suddenly?

For prolonged topical corticosteroid therapy, sudden discontinuation may lead to issues due to the risk of HPA-axis suppression (adrenal suppression). For prolonged therapy, regulatory texts indicate that gradual withdrawal of the medicine is often recommended to support HPA-axis recovery.


Q: Does Cinoderm carry a specific warning about mental health side effects?

Systemic absorption of the corticosteroid, especially with prolonged use, is documented to have potential neurologic and psychiatric adverse reactions. These reactions can include changes in mood, behavior, or sleep patterns.


Q: What is the meaning of the warning about 'serious' side effects associated with Cinoderm?

Serious side effects refer to documented, potentially severe risks that, while rare, can lead to significant harm. These include HPA-axis suppression (adrenal function changes), Ototoxicity (hearing damage), and Nephrotoxicity (kidney damage), which are associated with the active components if absorbed in high amounts.


Q: Are there any documented cases of Cinoderm interacting with herbal supplements?

Official drug interaction lists typically focus on pharmaceutical products and do not explicitly name herbal supplements. However, because the active ingredients can be absorbed, there is a potential for unknown interactions. All supplements are generally recommended for review with a healthcare professional due to the potential for unknown interactions.


Q: Can Cinoderm cause changes in appetite or weight?

In some cases, systemic absorption of the corticosteroid component may lead to signs similar to Cushing's syndrome. These manifestations can include weight gain, particularly in the face and body, and changes in appetite.


Q: Does Cinoderm interact with alcohol?

Official regulatory documents typically do not list alcohol as a specific interaction for topical products. Nevertheless, any potential use of alcohol while undergoing treatment is usually reviewed by a professional, particularly due to the systemic effects associated with corticosteroids.


Q: If I have liver problems, can I still use Cinoderm?

Corticosteroids are primarily processed by the liver. Official documentation indicates that patients with existing liver issues generally inform their healthcare professional, as impaired liver function may affect how the body metabolizes the medicine.


Q: Is Cinoderm a controlled substance?

Cinoderm is classified as a prescription medicine containing a corticosteroid and an antibiotic. Based on US federal classification, its active components are generally not listed as controlled substances under the Controlled Substances Act (CSA).


Q: Are there different strengths or formulations of Cinoderm available?

Yes, Cinoderm is available in different strengths of the Triamcinolone Acetonide component. It is also supplied in different topical formulations, such as a cream or an ointment.


Q: How long does Cinoderm stay in a person's system?

The amount of time the active ingredients remain in the body varies significantly, depending on how much is absorbed through the skin. The Triamcinolone Acetonide component has a measured systemic half-life, but overall absorption is highly variable among individuals.


Q: Does Cinoderm have special considerations for people with diabetes?

Yes. Corticosteroids can cause an increase in glucose (sugar) levels in the blood or urine due to systemic absorption. Patients with diabetes typically inform their healthcare professional, as close monitoring of blood sugar may be necessary.


Q: What is the role of Cinoderm in managing chronic conditions?

The medication is designed for conditions that respond to anti-inflammatory and anti-infective therapy. However, official guidance strictly limits its use to short-term administration due to the associated risks of prolonged corticosteroid use.


Q: What are the signs that Cinoderm is working?

The medicine is indicated for the relief of inflammatory and pruritic manifestations. Signs that the medicine is having its intended effect typically include a reduction in symptoms such as redness (erythema), swelling (edema), and severe itching (pruritus) in the treated skin area.


Q: Is it safe to take Cinoderm with common vitamins or minerals?

Official interaction lists do not typically include common vitamins or minerals. However, professional guidance is generally recommended regarding the use of supplements while undergoing treatment, as some supplements may be relevant to systemic health when using a corticosteroid that can be absorbed.


Q: Is it possible to become dependent on Cinoderm?

While not described as addiction or drug dependence, prolonged use can cause a physiological effect called HPA-axis suppression. This means the body's natural hormone production may temporarily rely on the medication, necessitating gradual withdrawal under professional guidance.


Q: Are there any common reasons why a doctor might decide to stop prescribing Cinoderm?

A healthcare professional may stop the medication if a patient experiences a hypersensitivity (allergic reaction), if there is no therapeutic benefit, if a skin infection worsens, or if there are signs of systemic side effects, such as HPA-axis suppression.


Q: Does Cinoderm carry a boxed warning?

Official documents outline serious risks associated with systemic absorption, including potential Ototoxicity (hearing damage) and Nephrotoxicity (kidney damage) from the Neomycin component. However, the regulatory text provided does not explicitly confirm or deny if this specific topical product carries a formal FDA Boxed Warning.

How should Cinoderm be stored and disposed of?

Cinoderm (a topical corticosteroid/antibiotic combination) must be stored strictly according to official regulatory documentation to maintain product stability and safety.

Official Storage Requirements

Detail Requirement
Temperature Store at controlled room temperature, typically 15° C to 30° C (59° F to 86° F).
Handling Do not refrigerate or freeze the product.
Protection Keep in the tightly closed container and protect from excessive heat, moisture, and direct light.
Child Safety Keep out of sight and reach of children.

Official Disposal Instructions

Unused or expired Cinoderm must be disposed of following local regulatory requirements, preferably through an official drug take-back program. If no program is available, the product should be prepared by mixing it with an undesirable substance, sealing it in a bag, and placing it in the household trash. The medication must not be flushed down a toilet or drain to prevent environmental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cinoderm found in:

A-Z Index: